Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00692302 · ClinicalTrials.gov registry record · Phase 1

Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)

A Phase 1 study of Suicide, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 1
Development phase
72
Enrollment target
1
Study location

NCT00692302: Completed Phase 1 study of Suicide, sponsored by University of California, Los Angeles.

NCT00692302 is a Phase 1 study of Suicide that has completed, run by University of California, Los Angeles. The registered enrollment target is 72 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00692302, a Phase 1 study of Suicide, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 1
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of an individually tailored suicide prevention treatment program called SAFETY in reducing suicide and suicide attempts in adolescents.

Primary Outcome

Derived from adapted C-SSRS that incorporates questions from the Suicide History Interview

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced usual care
  • BEHAVIORAL SAFETY

Study Locations (1)

California

  • University of California - Los Angeles

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2006-03
Est. Completion 2019-10-18
Phase Phase 1

What the finished NCT00692302 record still lists

NCT00692302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Enhanced usual care is the first listed.

NCT00692302 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00692302 about?

NCT00692302 is a clinical study titled "Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)". This study will evaluate the effectiveness of an individually tailored suicide prevention treatment program called SAFETY in reducing suicide and suicide attempts in adolescents.

What is the current status of trial NCT00692302?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2006-03. Estimated completion is 2019-10-18.

What conditions does trial NCT00692302 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT00692302?

The interventions under investigation include: Enhanced usual care (BEHAVIORAL), SAFETY (BEHAVIORAL).

Who is sponsoring clinical trial NCT00692302?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00692302 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00692302's enrollment target sits among peer trials

72 59th of 92 higher than 34 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00692302, the US trial registry maintained by the National Library of Medicine. NCT00692302 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.